*It may take a few minutes for the email to arrive.
**Be sure to check your spam/junk folder.
If you’ve looked at your midsection lately and thought, “Cool. My jeans shrank in the wash,” you’re not alone. One of the most frustrating (and misunderstood) shifts in perimenopause and menopause is what happens to metabolic health, especially insulin sensitivity.
Here’s the deal: declining estrogen can make your body less responsive to insulin, which can increase the likelihood of insulin resistance during the menopause transition.
HotPause Health Medical Advisor and double board-certified Obesity and Family Medicine physician, Dr. Sejal Desai, breaks down what insulin resistance is, why it matters, what it can look like in real life (even when your “normal labs” look fine), and the evidence-backed options like lifestyle, medications, and yes, menopause hormone therapy for women who are candidates.
Insulin is a hormone your pancreas makes to help move sugar (glucose) from your bloodstream into your cells, where it’s used for energy. When your cells respond well, insulin does its job efficiently.
With insulin resistance, your cells become less responsive, so your pancreas often compensates by producing more insulin to keep blood sugar stable. Over time, this compensation can break down, raising the risk of prediabetes, type 2 diabetes, fatty liver disease, and cardiovascular disease.
Because insulin resistance is not just “a blood sugar thing.” It’s a whole-body risk amplifier. It’s tightly linked to cardiometabolic risk. And heart disease is the leading cause of death for women in the U.S. So yes, we care about weight changes and energy and brain fog, but we care even more about what’s happening under the hood.
There are multiple drivers, and they tend to stack:
1) Estrogen declines, and insulin sensitivity can follow
Estrogen plays a role in metabolic regulation. As levels fall during the menopause transition, insulin sensitivity can worsen in some women.
2) Body composition shifts
Many women notice weight gain, more central (abdominal or visceral) fat and less lean muscle over time. Visceral fat is more metabolically active (and inflammatory) than subcutaneous fat. Menopause is associated with increased abdominal/visceral fat and cardiometabolic risk.
3) Sleep and stress are not “soft factors”
Inadequate sleep (inconsistent, short duration and poor quality) is associated with worse glucose regulation and higher cardiometabolic risk. Large cohort data link shorter sleep duration with higher risk of type 2 diabetes.
4) Modern food + modern life
Highly processed foods, frequent snacking, sweet drinks, chronic stress, and sedentary workdays create the perfect storm, at exactly the life stage when hormones stop buffering the impact.
Sometimes it’s loud. Often it’s sneaky. Common experiences include:
Many routine annual panels and labs don’t include fasting insulin, and early insulin resistance can exist even when glucose and A1C haven’t moved yet. A more complete evaluation often includes:
Practical note: interpretation varies by lab and clinical context, this is where a clinician who actually understands metabolic health is worth their weight in gold.
There is no single magic lever, but there are several high-impact ones. Start where you are, and build.
1) Strength training (because muscle is metabolic)
Lean muscle is a major sink for glucose. Resistance training supports insulin sensitivity and body composition, both of which tend to shift in midlife. Baseline targets (U.S. guidelines):
2) Eat for glucose stability: protein + fiber + whole foods
Think: fewer glucose spikes, more satiety, more nutrient density. Helpful habits:
3) Sleep like it’s your job
Because it kind of is. Short or disrupted sleep can worsen insulin sensitivity and glucose regulation. If insomnia is part of your menopause experience, treat it as a real medical issue.
4) Time-restricted eating / intermittent fasting (for some people)
Not everyone loves it, and it’s not appropriate for everyone, but research suggests fasting regimens can improve markers like fasting glucose in some populations. If you have a history of disordered eating, significant anxiety around food, or certain medical conditions, talk with your clinician before experimenting here.
Hormone replacement therapy (HRT) is best known for treating symptoms like hot flashes and night sweats, but there’s growing interest in its metabolic effects.
A major systematic review and meta-analysis of 17 randomized, placebo-controlled trials found that hormone therapy significantly reduced insulin resistance in healthy, non-diabetic postmenopausal women, with estrogen-alone generally showing a larger effect than estrogen + progestogen.
Important nuance:
For women who are already doing “the right things” and still struggling, or who have prediabetes, type 2 diabetes, or other metabolic risk, medication can be appropriate. Options your clinician might discuss include:
These are prescription decisions, not DIY territory, but if you’ve been white-knuckling your way through lifestyle changes with no traction, you deserve a real conversation about medical options.
If you’re in perimenopause or menopause and thinking, “My body is ignoring the rules it used to follow,” you’re not imagining it. Insulin resistance can be part of the midlife metabolic shift, and it’s worth addressing early, before it snowballs into prediabetes or cardiovascular risk. Start with the fundamentals:
0